1. Home
  2. LRN vs VERA Comparison

LRN vs VERA Comparison

Compare LRN & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stride Inc.

LRN

Stride Inc.

SELL

Current Price

$78.79

Market Cap

3.5B

Sector

Real Estate

ML Signal

SELL

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$29.76

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LRN
VERA
Founded
2000
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.0B
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
LRN
VERA
Price
$78.79
$29.76
Analyst Decision
Hold
Strong Buy
Analyst Count
3
14
Target Price
★ $109.00
$77.50
AVG Volume (30 Days)
556.9K
★ 2.2M
Earning Date
10-27-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 20.00
N/A
EPS
★ 7.14
N/A
Revenue
★ $917,734,000.00
N/A
Revenue This Year
$2.03
N/A
Revenue Next Year
$4.47
$792.38
P/E Ratio
$10.86
★ N/A
Revenue Growth
★ 3.29
N/A
52 Week Low
$60.61
$23.05
52 Week High
$155.06
$56.05

Technical Indicators

Market Signals
Indicator
LRN
VERA
Relative Strength Index (RSI) 45.06 36.29
Support Level $77.37 N/A
Resistance Level $88.18 $36.95
Average True Range (ATR) 2.20 2.09
MACD -0.11 -0.41
Stochastic Oscillator 45.26 11.38

Price Performance

Historical Comparison
LRN
VERA

About LRN Stride Inc.

Stride Inc is a technology company providing an educational platform to deliver proprietary and third-party curriculum, software systems, and educational services designed to facilitate individualized learning for students and adults throughout the U.S. The platform delivers products and services to attract, enroll, educate, track progress, and support students. It provides customized solutions to public and private schools, school districts, charter boards, employers, government agencies, and consumers. Its platform addresses two markets in the K-12 space: General Education and Career Learning, with products and services for the General Education market predominantly focused on core subjects for kindergarten through twelfth grade students.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: